Slingshot members are tracking this event:

Gilead (GILD) Announces Top-Line Phase 2 Data for GS-4997 in Nonalcoholic Steatohepatitis (NASH)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 20, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Top-line, Phase 2, Gs-4997, Selonsertib, Nonalcoholic Steatohepatitis, Nash